Sonam Dhamija

Title: Sonam Dhamija: Innovator in SARS-CoV-2 Detection

Introduction

Sonam Dhamija is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of biotechnology, particularly in the detection of SARS-CoV-2. His innovative work has implications for public health and disease management.

Latest Patents

Sonam Dhamija holds a patent for a method of detecting the presence of SARS-CoV-2 using oligonucleotide primer pairs. The patent, titled "Primer sets, biomarkers, kit and applications thereof," discloses oligonucleotide primer pairs for the detection of SARS-CoV-2 using polymerase chain reaction (PCR)-based methods. Additionally, it includes biomarkers and probes for SARS-CoV-2 detection. The disclosure also relates to the identification and isolation of biomarkers for use as probes for the detection of SARS-CoV-2, as well as their potential use as targets for the development of drug targets and therapeutics for SARS-CoV-2. This patent highlights his innovative approach to addressing a critical global health issue.

Career Highlights

Sonam Dhamija is affiliated with the Indian Institute of Technology Delhi, where he conducts research and development in biotechnology. His work has garnered attention for its practical applications in combating viral infections.

Collaborations

He collaborates with notable colleagues, including Bishwajit Kundu and Akhilesh Mishra, to advance research in his field. Their combined expertise contributes to the development of effective solutions for public health challenges.

Conclusion

Sonam Dhamija's contributions to the detection of SARS-CoV-2 through innovative patenting demonstrate his commitment to advancing biotechnology. His work not only enhances diagnostic capabilities but also paves the way for future therapeutic developments.